146 related articles for article (PubMed ID: 18628787)
21. Association of a CAV-1 haplotype to familial aggressive prostate cancer.
Haeusler J; Hoegel J; Bachmann N; Herkommer K; Paiss T; Vogel W; Maier C
Prostate; 2005 Oct; 65(2):171-7. PubMed ID: 15948133
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.
Lindmark F; Jonsson BA; Bergh A; Stattin P; Zheng SL; Meyers DA; Xu J; Grönberg H
Prostate; 2004 May; 59(2):132-40. PubMed ID: 15042613
[TBL] [Abstract][Full Text] [Related]
23. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
[TBL] [Abstract][Full Text] [Related]
24. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.
FitzGerald LM; Thomson R; Polanowski A; Patterson B; McKay JD; Stankovich J; Dickinson JL
Prostate; 2008 Sep; 68(13):1373-9. PubMed ID: 18537123
[TBL] [Abstract][Full Text] [Related]
25. The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk.
Xu J; Lowey J; Wiklund F; Sun J; Lindmark F; Hsu FC; Dimitrov L; Chang B; Turner AR; Liu W; Adami HO; Suh E; Moore JH; Zheng SL; Isaacs WB; Trent JM; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2563-8. PubMed ID: 16284379
[TBL] [Abstract][Full Text] [Related]
26. Utility of incorporating genetic variants for the early detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
[TBL] [Abstract][Full Text] [Related]
27. Association of chromosomal locus 8q24 and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A; Schürmann P; Ghahremani M; Kocak E; Brinkhaus MJ; Bremer M; Karstens JH; Hagemann J; Machtens S; Dörk T
Urol Oncol; 2009; 27(4):373-6. PubMed ID: 18625567
[TBL] [Abstract][Full Text] [Related]
28. Manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with risk of early-onset prostate cancer.
Arsova-Sarafinovska Z; Matevska N; Petrovski D; Banev S; Dzikova S; Georgiev V; Sikole A; Sayal A; Aydin A; Suturkova L; Dimovski AJ
Cell Biochem Funct; 2008 Oct; 26(7):771-7. PubMed ID: 18646267
[TBL] [Abstract][Full Text] [Related]
29. Effect of genetic variability within 8q24 on aggressiveness patterns at diagnosis and familial status of prostate cancer.
Cussenot O; Azzouzi AR; Bantsimba-Malanda G; Gaffory C; Mangin P; Cormier L; Fournier G; Valeri A; Jouffe L; Roupret M; Fromont G; Sibony M; Comperat E; Cancel-Tassin G
Clin Cancer Res; 2008 Sep; 14(17):5635-9. PubMed ID: 18765558
[TBL] [Abstract][Full Text] [Related]
30. The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
Scariano JK; Treat E; Alba F; Nelson H; Ness SA; Smith AY
Prostate; 2008 Dec; 68(16):1798-805. PubMed ID: 18780294
[TBL] [Abstract][Full Text] [Related]
31. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Cox DG; Blanché H; Pearce CL; Calle EE; Colditz GA; Pike MC; Albanes D; Allen NE; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Canzian F; Chanock S; Clavel-Chapelon F; Feigelson HS; Freedman M; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; Kraft P; LeMarchand L; Lund E; Palli D; Peeters PH; Riboli E; Stram DO; Thun M; Tjonneland A; Trichopoulos D; Yeager M;
Breast Cancer Res; 2006; 8(5):R54. PubMed ID: 16987421
[TBL] [Abstract][Full Text] [Related]
33. MUC1 and estrogen receptor alpha gene polymorphisms in dry eye patients.
Imbert Y; Foulks GN; Brennan MD; Jumblatt MM; John G; Shah HA; Newton C; Pouranfar F; Young WW
Exp Eye Res; 2009 Mar; 88(3):334-8. PubMed ID: 18619437
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.
Kesarwani P; Mandhani A; Mittal RD
J Urol; 2009 Dec; 182(6):2938-43. PubMed ID: 19846139
[TBL] [Abstract][Full Text] [Related]
35. Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.
Larson GP; Ding Y; Cheng LS; Lundberg C; Gagalang V; Rivas G; Geller L; Weitzel J; MacDonald D; Archambeau J; Slater J; Neuberg D; Daly MB; Angel I; Benson AB; Smith K; Kirkwood JM; O'Dwyer PJ; Raskay B; Sutphen R; Drew R; Stewart JA; Werndli J; Johnson D; Ruckdeschel JC; Elston RC; Krontiris TG
Cancer Res; 2005 Feb; 65(3):805-14. PubMed ID: 15705877
[TBL] [Abstract][Full Text] [Related]
36. CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis.
Shaik AP; Jamil K; Das P
Urol J; 2009; 6(2):78-86. PubMed ID: 19472123
[TBL] [Abstract][Full Text] [Related]
37. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
38. Association of rs6983561 polymorphism at 8q24 with prostate cancer mortality in a Japanese population.
Suzuki M; Liu M; Kurosaki T; Suzuki M; Arai T; Sawabe M; Kasuya Y; Kato M; Fujimura T; Fukuhara H; Enomoto Y; Nishimatsu H; Ishikawa A; Kume H; Homma Y; Kitamura T
Clin Genitourin Cancer; 2011 Sep; 9(1):46-52. PubMed ID: 21700508
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysis.
Zhang Z; Wang S; Wang M; Tong N; Fu G; Zhang Z
Carcinogenesis; 2008 Oct; 29(10):1973-8. PubMed ID: 18684727
[TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis transmembrane conductance regulator (CFTR) gene 5T allele may protect against prostate cancer: a case-control study in Chinese Han population.
Qiao D; Yi L; Hua L; Xu Z; Ding Y; Shi D; Ni L; Song N; Wang Y; Wu H
J Cyst Fibros; 2008 May; 7(3):210-4. PubMed ID: 17761461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
